Results 1 to 10 of about 2,146,909 (263)

Trends and Costs of US Telehealth Use Among Patients With Cardiovascular Disease Before and During the COVID‐19 Pandemic

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The COVID‐19 pandemic affected outpatient care delivery and patients' access to health care. However, no prior studies have documented telehealth use among patients with cardiovascular disease.
Jun Soo Lee, Kincaid Lowe Beasley, Michael W. Schooley, Feijun Luo   +3 more
doaj   +1 more source

Social Determinants of Health–Related Z Codes and Health Care Among Patients With Hypertension

AJPM Focus, 2023
Introduction: Tracking social needs can provide information on barriers to controlling hypertension and the need for wraparound services. No recent studies have examined ICD-10-CM social determinants of health–related Z codes (Z55–Z65) to indicate social
Jun Soo Lee, PhD, Kara E. MacLeod, DrPH, Elena V. Kuklina, MD, PhD, Xin Tong, MPH, Sandra L. Jackson, PhD   +4 more
doaj   +1 more source

Changing Spatiotemporal Trends in County‐Level Heart Failure Death Rates in the United States, 1999 to 2018

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Amid recently rising heart failure (HF) death rates in the United States, we describe county‐level trends in HF mortality from 1999 to 2018 by racial/ethnic group and sex for ages 35 to 64 years and 65 years and older.
Adam S. Vaughan, Mary G. George, Sandra L. Jackson, Linda Schieb, Michele Casper   +4 more
doaj   +1 more source

Progress Toward Achieving National Targets for Reducing Coronary Heart Disease and Stroke Mortality: A County‐Level Perspective

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background The American Heart Association and Healthy People 2020 established objectives to reduce coronary heart disease (CHD) and stroke death rates by 20% by the year 2020, with 2007 as the baseline year.
Adam S. Vaughan, Rebecca C. Woodruff, Christina M. Shay, Fleetwood Loustalot, Michele Casper   +4 more
doaj   +1 more source

County‐Level Trends in Hypertension‐Related Cardiovascular Disease Mortality—United States, 2000 to 2019

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Amid stagnating declines in national cardiovascular disease (CVD) mortality, documenting trends in county‐level hypertension‐related CVD death rates can help activate local efforts prioritizing hypertension prevention, detection, and control ...
Adam S. Vaughan, Fátima Coronado, Michele Casper, Fleetwood Loustalot, Janet S. Wright   +4 more
doaj   +1 more source

Million Hearts: Description of the National Surveillance and Modeling Methodology Used to Monitor the Number of Cardiovascular Events Prevented During 2012–2016

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
Background This study describes the national surveillance and modeling methodology developed to monitor achievement of the Million Hearts initiative's aim of preventing 1 million acute myocardial infarctions, strokes, and other related cardiovascular ...
Matthew D. Ritchey, Fleetwood Loustalot, Hilary K. Wall, Claudia A. Steiner, Cathleen Gillespie, Mary G. George, Janet S. Wright   +6 more
doaj   +1 more source

Antihypertensive Medication Adherence and Risk of Cardiovascular Disease Among Older Adults: A Population‐Based Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundAntihypertension medication (antihypertensive) adherence lowers risk of cardiovascular disease (CVD); few studies have examined this association among older adults.
Quanhe Yang, Anping Chang, Matthew D. Ritchey, Fleetwood Loustalot   +3 more
doaj   +1 more source

Policy implementation strategies to address rural disparities in access to care for stroke patients

Frontiers in Health Services, 2023
ContextStroke systems of care (SSOC) promote access to stroke prevention, treatment, and rehabilitation and ensure patients receive evidence-based treatment.
Aysha Rasool, Aysha Rasool, Moriah Bailey, Brittany Lue, Nina Omeaku, Adebola Popoola, Sharada S. Shantharam, Amanda A. Brown, Erika B. Fulmer   +8 more
doaj   +1 more source

Risk of Cardiovascular Disease After COVID‐19 Diagnosis Among Adults With and Without Diabetes

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Growing evidence suggests incident cardiovascular disease (CVD) may be a long‐term outcome of COVID‐19 infection, and chronic diseases, such as diabetes, may influence CVD risk associated with COVID‐19.
Alain K. Koyama, Giuseppina Imperatore, Deborah B. Rolka, Elizabeth Lundeen, Rachel E. Rutkowski, Sandra L. Jackson, Siran He, Elena V. Kuklina, Soyoun Park, Meda E. Pavkov   +9 more
doaj   +1 more source

Time Course of Evolution of Disability and Cause‐Specific Mortality After Ischemic Stroke: Implications for Trial Design

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundOutcome in stroke trials is often based on a 3‐month modified Rankin scale (mRS). How 3‐month mRS relates to longer‐term outcomes will depend on late recovery, delayed stroke‐related deaths, recurrent strokes, and nonstroke deaths. We evaluated
Aravind Ganesh, Ramon Luengo‐Fernandez, Rose M. Wharton, Sergei A. Gutnikov, Louise E. Silver, Ziyah Mehta, Peter M. Rothwell   +6 more
doaj   +1 more source